Philippe ParoneDirector, Industrialization at Celyad, Belgium
Philippe Parone, Ph.D., is the Director for Industrialization at Celyad. Prior to Celyad, Dr. Parone worked at Fate Therapeutics overseeing the development of cell therapy product candidates derived from hematopoietic stem cells and iPSCs for the treatment of autoimmune disorders. During his time at Fate therapeutics, Dr. Parone was part of the team that filed the INDs for the first U.S. clinical investigation of an iPSC-derived cell product and the world’s first cell therapy derived from an engineered iPSC. Dr. Parone holds a PhD in Biochemistry and Cell biology from the University of Cambridge and received his B.S. in Biology from the University of East Anglia.